SciCombinator

Discover the most talked about and latest scientific content & concepts.

Effectiveness of Seven and Thirteen Valent Pneumococcal Conjugate Vaccines in a Schedule without a Booster dose: a Ten Year Observational Study

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 23 Feb 2018

S Jayasinghe, C Chiu, H Quinn, R Menzies, R Gilmour and P McIntyre
Abstract
Uniquely among high income countries, Australia uses a 3+0 schedule (3 primary doses; no booster) for infant pneumococcal conjugate vaccine since January 2005, initially 7-valent (PCV7) then 13-valent (PCV13) from July 2011. We measured vaccine effectiveness (VE) of both PCVs against invasive pneumococcal disease (IPD) by two methods.
Tweets*
12
Facebook likes*
0
Reddit*
0
News coverage*
5
Blogs*
0
SC clicks
0
Concepts
Vaccination, Vaccination schedule, Pneumococcal vaccine, Pneumococcal polysaccharide vaccine, Vaccine, Streptococcus pneumoniae, Pneumonia, Pneumococcal conjugate vaccine
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com